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Aneuploidy originates from chromosome 
 segregation errors during the two highly regu­
lated programs of cell division: mitosis and 
meiosis. Meiosis differs significantly from 
mitosis in that it reduces the number of chro­
mosomes in half to produce haploid gametes: 
the egg and sperm. Human female meiosis, 
in particular, is inherently prone to errors, 
as evidenced by the high incidence and com­
plexity of aneuploidies in stillbirths and spon­
taneous abortions (Hassold and Hunt 2001). 
While the etiology of aneuploidy is incom­
pletely understood, evidence from mamma­
lian studies suggests that exposure to diverse 
chemicals, including chemo therapeutic 
agents, alcohol, plastics, and pesticides, may 
be causative (Hales et al. 2005; Harkonen 
2005; Hunt et al. 2003). However, despite 
the relevance of meiotic aneuploidies for 
reproductive health, we are currently unable 
to efficiently and comprehensively interrogate 
the multitude of chemicals in the environ­
ment for their effect on germ line function 
and reproductive health.
Several  programs at the National 
Institutes of Health (NIH), the U.S. Food 
and Drug Administration (FDA), and the 
U.S. Environmental Protection Agency (EPA) 
have identified a critical need in chemical risk 
assessment and initia ted large­scale research 
programs (e.g., ToxCast, Tox21) using high 
throughput screening (HTS) assays for predic­
tive toxicology (Dix et al. 2007; Kavlock et al. 
2012; Krewski et al. 2010). In line with these 
efforts, we have developed an HTS platform 
for environ mental toxicants based on germ line 
dysfunction in the roundworm Caenorhabditis 
elegans. C. elegans offers significant advantages 
for this purpose: a) a high degree of conserva­
tion of key mammalian meiotic pathways, b) a 
well­studied model system of meiosis, and 
c) a vast array of available cyto logical, genetic, 
and biochemical tools (Colaiácovo 2006). Of 
particular interest was the use of C. elegans in a 
novel first­tier HTS strategy that would detect 
abnormal chromosome numbers. We chose to 
focus on environmental disruption of female 
meiosis because mammalian oogenesis encom­
passes events from early embryonic stages to 
adulthood and is therefore especially difficult 
to study. Here, we report the development of 
a platform that rapidly and comprehensively 
interrogates the landscape of environmental 
chemicals for potential effects on germ line 
function, induction of aneuploidy, and pre­
diction of mammalian reproductive deficits.
Materials and Methods
C. elegans genetics and growth conditions. 
C. elegans strains were cultured as described 
by Brenner (1974) at 20°C on nema­
tode growth medium (NGM) plates. The 
N2 Bristol strain was used as the wild­type 
strain. The following mutations and chromo­
some rearrangements were used in this 
study: LGIV, col-121(nx3), him-8(e1489); 
L G V ,  y I s 3 4 [ P x o l - 1 : : G F P ,  r o l - 6 ] , 
bcIs39[Plim-7::ced-1::GFP, lin-15].
Drug treatments and screening procedure. 
All chemicals were purchased from Sigma­
Aldrich (St. Louis, MO) and dissolved in 
dimethyl sulfoxide (DMSO; 0.1 M). Only 
chemicals that were dissolvable in DMSO at 
0.1 M were considered for this screen. Final 
DMSO and chemical concentrations were 
0.1% and 100 µM, respectively, except for 
mancozeb, dicofol, 2­(thiocyanomethylthio) 
benzothiazole (TCMTB), phosalone, chloro­
phene, endo sulfan, and parathion­methyl, 
which were further diluted 10­fold to circum­
vent lethality. Chlorpyrifos­ methyl was used at 
1 µM for the same reason.
We synchronized an adult C. elegans 
popu lation with sodium hypochloride treat­
ment in order to generate age­matched 
embryos (Stiernagle 2006). The embryos were 
cultured on eight 10­cm NGM plates seeded 
with bacteria for 3 days at 20°C to gener­
ate a large pool of L4­stage worms that was 
resuspended in M9 buffer with bacteria. Live 
bacteria were used as described in numerous 
other chemical screens using C. elegans (e.g., 
Boyd et al. 2010a, 2010b), which, considering 
the screen’s relatively low false­positive and 
­negative rates, is not likely to be detrimental 
to this assay. After quantification under the 
microscope of the number of worms in popu­
lation samples, 300 worms were dispensed 
in each well of a 24­well plate to which the 
chemicals were subsequently added. Each 
plate contained a negative control (0.1% 
DMSO) as well as a positive control (100 µM 
nocodazole). The worms were then incubated 
with shaking for either 24 hr or 65 hr at 25°C. 
After this incubation, the worms were trans­
ferred to 1.5­mL tubes, settled by gravity, and 
washed in M9 before being transferred to a 
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Background: Despite the developmental impact of chromosome segregation errors, we lack the 
tools to assess environmental effects on the integrity of the germ line in animals.
oBjectives: We developed an assay in Caenorhabditis elegans that fluorescently marks aneuploid 
embryos after chemical exposure.
Methods: We qualified the predictive value of the assay against chemotherapeutic agents as well as 
environmental compounds from the ToxCast Phase I library by comparing results from the C. elegans 
assay with the comprehensive mammalian in vivo end point data from the ToxRef database.
results: The assay was highly predictive of mammalian reproductive toxicities, with a 69% 
maximum balanced accuracy. We confirmed the effect of select compounds on germ line integrity by 
monitoring germ line apoptosis and meiotic progression.
conclusions: This C. elegans assay provides a comprehensive strategy for assessing environmental 
effects on germ line function.
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slide and mounted with a coverslip for assess­
ment of GFP+ embryos under an upright fluo­
rescent microscope (Leica, Buffalo Grove, IL).
All statistical analyses performed after the 
C. elegans screen used the two­tailed Mann–
Whitney U test with a 95% confidence inter­
val (CI) unless specified otherwise.
Predictivity analysis. To assess the pre­
dictive value of the C. elegans screen against 
mammalian in vivo reproductive toxic­
ity data, Toxicological Reference Database 
(ToxRefDB) (Martin et al. 2009) end points 
indicative of decreased female fertility were 
dichotomized with respect to their lowest effect 
level in a multigenerational study (MG­LEL). 
There were 47 compounds with multi­
generational reproductive toxicity study data. 
Of those compounds, 20 had an MG­LEL 
of ≤ 500 mg/kg/day and were considered pos­
itive reproductive toxicants, and 27 had no 
MG­LEL in that range and were considered 
negatives. A subset of 7 compounds did not 
have associated ToxRefDB data; these were 
excluded from this portion of the analysis. The 
fold­change cutoff criteria for a positive hit in 
the C. elegans assay was iteratively increased 
from the lowest observed value in the assay 
to the highest, and sensitivity (true positive 
rate), specificity (true negative rate), and bal­
anced accuracy (the average of sensitivity and 
specificity) were calculated for each cutoff 
value. A similar procedure based on iteratively 
increasing the cutoff value in the C. elegans 
assay at each time point and calculating the 
relative risk was followed for each individual 
multigenerational end point (with > 2 posi­
tive compounds). Statistical analysis was per­
formed using R, version 2.13.0 (R Foundation, 
Vienna, Austria) [for code, see Supplemental 
Material, pp. 10–11, and Supplemental 
Source Code (http://dx.doi.org/10.1289/
ehp.1206301)].
Embryonic viability measurement . 
Embryonic viability was performed three 
times for each exposure as described by Allard 
and Colaiácovo (2010). Briefly, the num­
bers of eggs laid and larvae hatched were 
recorded after a 24­hr exposure to DMSO and 
nocodazole.
Apoptosis assay and germ line nuclear 
analysis. Quantitative analysis of germ cell 
apoptosis was performed using the Plim-
7::ced-1::GFP strain as described by Saito 
et al. (2009). High­resolution images of germ­
line defects were captured and processed as 
described by Allard and Colaiácovo (2010).
Automated fluorescence reading. A COPAS 
BIOSORT (Union Biometrica, Holliston, 
MA) was used for automated worm reading 
and sorting. Briefly, after a 24­hr exposure, 
the worms were washed at least three times in 
M9 buffer. The N2 wild­type strain was com­
pared with him8, Pxol-1::GFP to ascertain the 
presence of GFP+ embryos and adjust reading 
settings accordingly. The reading parameters 
used were time­of­flight (ToF) for the x­axis 
and GFP peak height for the y­axis. The num­
ber of events per sample was 5,000, except for 
the him-8 analysis where 1,000 events were 
read. A non­gated mixed population was used 
(mainly adults and embryos) from which only 
the objects of a size consistent with embryos 
were analyzed. The threshold to determine 
debris and GFP– versus GFP+ embryos was 
set using a control population of untreated 
wild­type worms.
Results
Establishing a chemical screen for embryonic 
aneuploidy. The strategy takes advantage of the 
rare proportion of male progeny (XO, < 0.2%) 
that naturally arises in wild­type hermaphro­
ditic (XX) populations as a result of a mei­
otic segregation error of the X chromosome 
(Hodgkin et al. 1979). As disruption of meio­
sis very frequently leads to increased non­
disjunction and aneuploidy, it correlates with 
a “high incidence of males” phenotype (Him), 
which is due to errors in X­chromosome seg­
regation. This phenotype is also accompanied 
by an elevated embryonic lethality that fol­
lows from errors in autosomal chromosome 
segregation (Dernburg et al. 1998; Hodgkin 
et al. 1979). To easily detect male embryos 
in utero and circumvent embryonic lethality, a 
male­specific promoter (xol-1) is used to drive 
expression of GFP. This allows a quick identi­
fication of male embryos by the appearance of 
“green eggs” within the worm’s hermaphrodite 
uterus. The Pxol-1::gfp transcriptional reporter 
strain has been used in the context of a genetic 
screen, named the “Green eggs and Him” 
screen, which led to the isolation of an allele of 
the meiotic recombination factor, msh-5 (Kelly 
et al. 2000; Nicoll et al. 1997).
We developed a chemical strategy using 
the Pxol-1::gfp strain (Figure 1). Specifically, 
liquid cultures of the strain are exposed to 
chemicals of interest at 100 µM, a concen­
tration commonly used in chemical screens 
in C. elegans (Boyd et al. 2010a, 2010b). 
The worm germ line consists of nuclei 
Figure 1. Design of the screening platform. (A) Worms from the aneuploidy-reporting Pxol-1::GFP strain are 
exposed to libraries of environmental compounds for either 24 hr or 65 hr. After exposure, the induction of 
aneuploidy can be visualized and quantified by fluorescence microscopy (B; bar = 100 µm) or automated 
detection and sorting of the worms (C). In B, several embryos expressing GFP (GFP+) can clearly be visual-
ized. C shows automated reading of the embryos. A population of GFP+ embryos can be detected as dis-
tinct from GFP– embryos and debris, which appear below the black bar.
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simultaneously moving from the distal to 
the proximal end of the gonad and progress­
ing through the meiotic stages in a synchro­
nous manner. This establishes a spatial and 
temporal gradient of meiotic progression in 
C. elegans, with a well­characterized timing 
of events (Jaramillo­Lambert et al. 2007; 
Pazdernik and Schedl 2013). Consequently, 
we exposed the worms for durations of 24 hr 
and 65 hr in order to capture the effects of 
exposure at distinct stages of germ line pro­
gression. Aneuploidies generated after a 
24­hr test interval arise from the impairment 
of late meiotic (late pachytene and onward) 
and early embryonic processes, whereas the 
65­hr interval captures aneuploidies originat­
ing from the disruption of any mitotic and 
meiotic events in the germ line in addition to 
early embryonic stages. After exposure, the 
worms were readily observed under a fluo­
rescence microscope. The number of GFP+ 
embryos were counted and normalized to the 
total number of embryos present to correct 
for decreased embryo production. We also 
established the automated detection and sort­
ing of the GFP+ worms by using the COPAS 
BIOSORT (Union Biometrica) for sorting 
of viable worms and embryos. The use of a 
flow cytometry sorting system allowed us to 
scale up the numbers of chemicals being tested 
and the speed of screening, thus enabling high 
throughput capability (see below).
To discriminate between germ line and 
embryonic chemically induced defects, we fol­
lowed the fluorescence screen with two assays: 
a) a reporter­based germ line apoptosis assay 
(Zhou et al. 2001), and b) DAPI­staining of 
the germ line nuclei. These two complementary 
tests respectively measure induction of the mei­
otic DNA damage checkpoint (Gartner et al. 
2008) and identify the nature of the germ line 
nuclear defects responsible for apoptotic induc­
tion and the generation of aneuploidy.
Chemical induction of aneuploidy in 
C. elegans and determination of aneugenic 
potency. Induction of aneuploidy in C. elegans 
has, to our knowledge, never been described 
in a chemical screening approach. To verify 
that Pxol-1::gfp reports chemical induction of 
aneuploidy, we tested exposure of these worms 
to the microtubule disruptor nocodazole. 
We expected nocodazole to promote chro­
mosome segregation errors during the germ­
line mitotic and late meiotic stages, as well 
as during early embryonic stages (Kitagawa 
and Rose 1999; Stear and Roth 2004). Thus, 
nocodazole should induce a high number of 
GFP+ embryos corresponding to increased 
X­chromosome mis segregation. Indeed, worms 
exposed to 100 µM nocodazole for either 
24 hr or 65 hr showed a statistically signifi­
cant increase in the number of GFP+ embryos 
compared with DMSO alone (p = 0.002, 
Figure 2A,C). The increase in GFP+ embryos 
correlated with a 64% average decrease in 
embryonic viability, consistent with autosome 
missegregation (Figure 2B) (Hodgkin 2005).
For qualification of the assay, we next 
tested a set of reference compounds (chemo­
therapeutic agents) of well­defined aneu­
genicity. These chemicals have been used 
extensively in in vitro and in vivo tests to 
determine their aneuploidy­inducing poten­
tial in mammalian settings. The mode of 
action and published data describing their 
mammalian aneugenicity is presented in 
Supplemental Material, Table S1 (http://
dx.doi.org/10.1289/ehp.1206301). We found 
that known aneugenic agents (bortezomib, 
dactino mycin, metho trexate, nocodazole, 
triethylene melamine, topotecan, vinblastine 
sulfate, and vincristine) were statistically sig­
nificant inducers of GFP+ embryos when com­
pared with DMSO at both 24­hr and 65­hr 
time points. We observed that over the com­
bined time points, seven of the eight aneu­
genic compounds were statistical hits, with 
microtubule drugs (nocodazole, vinblastine 
sulfate, and vincristine) showing the strongest 
levels of induction. Conversely, all four non­
aneugenic compounds tested (5­iodo tuber­
cidin, AG1478, allopurinol, and Tyr47) were 
Figure  2. Chemical induction of aneuploidy in C.  elegans. (A)  Pxol-1::GFP worms were exposed 
to 100 µm nocodazole or 0.1% DMSO (control) for 24 hr. Two GFP+ embryos are visible within the 
nocodazole-treated worm’s uterus (arrows) adjacent to the autofluorescence emanating from the gut; 
bar = 50 µm. (B) Embryonic viability (mean percent ± SE) after either DMSO or nocodazole exposure. 
(C) Chemotherapeutic screen; the worms were exposed for 24 hr or 65 hr to 100 µM of each compound. 
The number of GFP+ embryos per worm was recorded, corrected for the average number of embryos 
found in each worm, and expressed as the log fold ratio over DMSO (mean percent ± SE; two-tailed 
Mann–Whitney U test, 95% CI, chosen over ANOVA with post-test correction to test for significant differ-
ences for each compound over DMSO because of high differences in sample variance). Each chemical 
exposure was performed six times.
aLethal at 65 hr. *p ≤ 0.05, and **p ≤ 0.01, by two-tailed Mann–Whitney U test, 95% CI.
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not different from controls (Figure 2C). The 
one false­negative, thioguanine, may have been 
missed because of the weak germ line expres­
sion in C. elegans of hypoxanthine phospho­
ribosyltransferase 1 (HPRT1), an enzyme 
important for the metabolism and toxicity 
of thioguanine (Kohara and Shin­i 2013). 
Finally, bortezomib was toxic at the 65­hr time 
point but positive at 24 hr. All together, these 
results indicate that the Pxol-1::GFP reporter 
strain can be used in a chemical screening 
setting to accurately discriminate compound 
aneugenicity.
Screening of environmental compounds 
with defined mammalian reproductive toxicity. 
We hypothesized that aneugenic compounds 
disrupting germ line chromosome segregation 
would likely cause reproductive impairment 
in mammals. Hence, aneugenic chemicals 
should be overrepresented among those whose 
exposure leads to decreased fertility and 
under represented among those showing no 
reproductive toxicity. To test this hypothesis, 
we mined the U.S. EPA’s ToxRefDB (http://
www.epa.gov/ncct/toxrefdb/). This extensive 
resource compiles over 30 years of mammalian 
in vivo toxicity data on 474 chemicals, primar­
ily pesticides and antimicrobials, and comprises 
several thousands of in vivo end points from 
chronic/subchronic carcinogenicity, prenatal 
developmental toxicity, and multigenerational 
reproductive toxicity studies (Knudsen et al. 
2009; Martin et al. 2009). The majority of the 
chemicals in the ToxRefDB, and all of those in 
the present study, also have associated in vitro 
HTS data in the U.S. EPA’s ToxCast program 
across hundreds of human gene and protein 
targets (Kavlock et al. 2012).
We tested the utility of the meiotic screen 
by comparing results from a panel of 47 com­
pounds with selected mammalian reproductive 
end points in ToxRefDB that were indica­
tive of decreased female fertility. These in vivo 
end points included decreased implanta tion 
sites, litter size, early postnatal pup survival, 
overall reproductive success, reproductive 
performance, and fertility as well as ovarian 
morphology defects. The selected compounds 
were grouped into three categories according 
to the number of mammalian end points they 
were positive for: a) high reproductive toxicity 
(32 end points), b) inter mediate reproductive 
toxicity (1 end point), and c) no reproduc­
tive toxicity (0 end points). The chemicals 
that were tested, their ranking by fold induc­
tion in the C. elegans assay, and their corre­
sponding mammalian in vivo end point data 
are presented in Supplemental Material, 
Tables S2 and S3 (http://dx.doi.org/10.1289/
ehp.1206301). As shown in Figure 3, at 
65 hr, there is a statistically significant parti­
tioning of all reproductive toxicants (high and 
intermediate) from compounds that are not 
reproductive toxicants (p = 0.008; two­tailed 
Mann–Whitney U test, 95% CI). The 24­hr 
exposure showed a trend toward significance 
(p = 0.08). These results indicate a clear enrich­
ment of reproductive toxicants as positive 
hits from the screen, suggesting that chemical 
aneugenicity is a likely source of reproductive 
toxicity in mammals.
Predicting mammalian reproductive 
impairment from the C. elegans screen. We 
next assessed the predictive value of the 
C. elegans screen with respect to mammalian 
in vivo reproductive toxicity data, where com­
pounds with an MG­LEL of ≤ 500 mg/kg/day 
were considered positive reproductive toxicants, 
and those with no MG­LEL in that range 
were considered negatives. This cutoff value 
approximates the reproductive test guideline 
testing limit of 1,000 mg/kg/day and accounts 
for the large uncertainty around dose mea­
surements and standard conversions applied 
across many studies and over 30 years of tox­
icity testing. There was a subset comprising 
Figure 3. Screening of environmental chemicals. Worms were exposed for either 24 hr (A) or 65 hr (B) 
to each compound, at a concentration of 100 µM [except for mancozeb, dicofol, 2-(thiocyanomethylthio) 
benzothiazole (TCMTB), phosalone, chloro phene, endo sulfan, parathion-methyl, which were further 
diluted 10-fold, and chlorpyrifos- methyl, which was used at 1 µM, to circumvent lethality]. The number 
of green embryos per worm was recorded and corrected for the average number of embryos found in 
each worm. The number was then expressed as the log fold ratio over DMSO. Chemicals are listed in 
order in Supplemental Material, Tables S2 and S3 (http://dx.doi.org/10.1289/ehp.1206301). The compounds 
were categorized according to their assessed mammalian reproductive toxicity [i.e., the number of mam-
malian end points for which they were positive: high reproductive toxicity (> 2 end points), intermediate 
reproductive toxicity (1 end point), and no reproductive toxicity (0 end points)]. At 65 hr, the mean value of 
fold-induction for the high and intermediate reproductive toxicity groups was significantly higher than the 
no–reproductive toxicity group (p = 0.008). Each chemical was tested three times.
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seven compounds that did not have associated 
ToxRefDB data; these seven compounds were 
excluded from this portion of the analysis. The 
data (log fold ratio over DMSO control) from 
both the 24­hr and 65­hr exposure intervals 
were used to predict mammalian reproductive 
toxicity. As shown in Supplemental Material, 
Figure S1A,B (http://dx.doi.org/10.1289/
ehp.1206301), we calculated the maximum 
balanced accuracy, which corresponds to the 
average of sensitivity (ability to correctly iden­
tify true positives) and specificity (ability to 
correctly identify true negatives) and is, there­
fore, a representation of the predictive value 
of the screen. The balanced accuracy was 68% 
for the 24­hr exposure at a cutoff of 1.6, and 
69% for the 65­hr exposure at a cutoff of 1.7. 
Interestingly, at these cutoff values the 24­hr 
exposure provided greater sensitivity (70%), 
whereas the 65­hr exposure provided greater 
specificity (78%). For the seven compounds 
without associated ToxRefDB guideline mul­
tigenerational study information, these cut­
off criteria identified three positives at both 
time points (dimethomorph, niclosamide, 
and fenitrothion), two positives at 24 hr only 
(clorophene and HPTE), and one positive 
(methoxychlor) at 65 hr only. One compound, 
prochloraz, was negative at both time points 
(see Supplemental Material, Tables S2 and S3).
We then calculated the relative risk and 
associated confidence intervals for each mam­
malian end point indicative of decreased 
female fertility by iteratively varying the cutoff 
for a positive result in the C. elegans assay, 
from the lowest observed value to the high­
est, at each time point. The maximum relative 
risks for each end point, corresponding to a 
C. elegans assay cutoff between 1 and 2 (log 
fold ratio over DMSO control), are shown in 
Table 1. In certain cases, higher cutoff val­
ues produced larger relative risks, but at the 
expense of large numbers of false­negatives 
and extreme confidence intervals; there­
fore, we have reported the maximum rela­
tive risks corresponding to a cutoff range that 
optimized the predictive value of the assay. 
A cutoff of 1.71 at the 65­hr time point pro­
duced the highest relative risk score (9.69) 
for the multigenerational rat end point of 
ovary microscopic and gross pathologies and 
weight changes (termed MGR_Rat_Ovary). 
Although the 65­hr time point was most 
predictive overall for any multigenerational 
end point, the remainder of the end points 
had maximal relative risk scores ranging from 
2.56 to 9.69 that were associated with cut­
off values of 1.43 to 1.80 at the 24­hr time 
point. Supporting the strong bias toward 
predicting reproductive impairment, the 
screen is not predictive of other unrelated 
end points such as mammalian liver geno­
toxicity [see Supplemental Material, Figure S2 
(http://dx.doi.org/10.1289/ehp.1206301)]. 
Together, the results show that the C. elegans 
screening strategy is predictive of mamma­
lian reproductive toxicity, with a balanced 
accuracy approaching 70% and significantly 
increased relative risk values for reproductive 
 impairment end points.
Analysis of meiotic defects from selected 
compounds. A critical aspect of the screen is the 
follow­up analysis, albeit not high throughput, 
of the chemical hits to discriminate between 
germ line versus early embryonic defects as the 
source of aneuploidy. To this end, we first 
monitored the activation of the late pachy­
tene meiotic checkpoint that leads to apoptotic 
clearing of nuclei carrying unrepaired DNA 
damage (Gartner et al. 2008). Here, we made 
use of a strain carry ing the Plim-7ced-1::gfp 
transgene to specifically mark engulfed nuclei 
undergoing apoptosis (Zhou et al. 2001), and 
we compared the 10 most aneugenic com­
pounds (based on fold change at 65 hr) with 
the 10 least aneugenic ones (Figure 4A). The 
difference in apoptotic levels between the two 
groups was extremely significant (p < 0.0001, 
by the two­tailed Mann–Whitney U test, 
95% CI). The statistical comparisons with 
vehicle control (DMSO) are shown in 
Figure 4A. The baseline of apoptotic levels 
were slightly elevated compared with DMSO, 
and a stringent statistical cutoff of p = 0.0001 
of comparison to DMSO was necessary to sep­
arate the most and least aneugenic chemicals. 
This test, however, clearly indicated a dramatic 
induction of germ line apoptosis in many of the 
top hits from the screen.
Next, we confirmed the presence of mei­
otic defects in the groups with high levels of 
apoptosis. Specifically, we observed severe 
germ line defects after exposure to the aneu­
genic compounds that also induced germ line 
apoptosis [Figure 4B; see also Supplemental 
Material, Table S4 (http://dx.doi.org/10.1289/
ehp.1206301)]. For example, worms exposed 
to the fungicide Maneb showed severe germ­
line disorganization including gaps or areas 
with a reduced density of nuclei (Figure 4B), 
which may be due to either impaired meiotic 
progression or the degeneration of a frac­
tion of nuclei, and a disorganization in the 
spatial/temporal gradient of meiotic stages 
(Figure 4B; evidence of intermixing of nuclei 
at different meiotic prophase stages). At the 
stage of diakinesis (end of prophase I), when 
fully cellularized oocytes are positioned in a 
single continuous row in wild­type worms, 
we also detected unevenly spaced nuclei, sug­
gesting a defect in cyto kinesis (white arrows). 
Interestingly, both gaps and intermixing of 
nuclei at different meiotic stages (red arrows) 
were also observed after exposure to the fun­
gicide TCMTB. None of these defects was 
observed in the DMSO­exposed control 
worms or in animals exposed to other com­
pounds (see Supplemental Material, Table S4). 
Together, these experiments strongly suggest a 
meiotic origin for the embryonic aneuploidy 
detected in the screen. This strategy therefore 
provides a fast and reliable tool to elucidate 
environmental influences on germ line function 
and predict mammalian reproductive toxicity.
High throughput adaptation and chemical 
sensitization. Finally, we propose a technology 
that can be readily applied in an HTS assay. 
We used an automated fluorescence­assisted 
sorter for large objects (COPAS BIOSORT, 
Union Biometrica) that can accurately read 
and sort whole animals as well as embryos 
from a suspension of worm culture (Boyd 
et al. 2010a, 2010b). To verify that the worm 
sorter can detect the presence of aneuploidy/
GFP+ embryos, we first sorted two genetically 
distinct worm populations: Pxol-1::gfp and 
Pxol-1::gfp; him-8(e1489) worms. HIM­8 is 
a protein that associates with a region known 
as the pairing center on the X chromosome 
in C. elegans whose activity is essential for 
the proper segregation of the X chromosome 
during meiosis (Hodgkin et al. 1979). Thus, 
him-8(e1489) mutants produce a high num­
ber of male progeny (approximately 30%) 
due to increased X­chromosome missegrega­
tion that can be easily visualized in the con­
text of the Pxol-1::gfp; him-8(e1489) strain 
(Figure 5A). Automated reading of the two 
populations easily identified a clear subset of 
GFP+ embryos that were present in much 
lower numbers in the Pxol-1::gfp worms alone, 
which allowed us to determine a threshold 
to discriminate between GFP+ and GFP– 
embryos and any remnants of culture debris.
Table 1. Relative risk.
Reproductive toxicity end point Relative risk (95% CI)
(+) Cutoff:  
C. elegans assay Time point
MGR_Rat_Fertility 4.05 (0.35, 46.60) 1.80 24 hr
MGR_Rat_LitterSize 6.82 (0.82, 56.76) 1.64 24 hr
MGR_Rat_Ovary 9.69 (1.11, 84.53) 1.71 65 hr
MGR_rat_ReproductiveOutcome 8.08 (1.11, 58.93) 1.43 24 hr
MGR_rat_ReproductivePerformance 9.45 (1.19, 74.85) 1.80 24 hr
MGR_Rat_ViabilityPND4 2.56 (1.49, 2.39) 1.64 24 hr
mgLEL (any) 2.15 (1.75, 2.64) 1.69 65 hr
Abbreviations: MGR, multigenerational; PND4, postnatal day 4. For each reproductive toxicity end point, relative risk 
was calculated by iteratively increasing the cutoff value (log fold ratio over DMSO control) for a positive result in the 
C. elegans assay at each time point. Maximum relative risks and 95% CIs are shown for cutoff values within a range 
shown to maximize the predictive value of the assay.
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Next, we tested the sorting of worms 
exposed to nocodazole and compared it with 
worms exposed to DMSO (control worms). 
Automated reading readily identified two 
distinct groups based on fluorescence levels, 
with approximately 3­fold induction between 
nocodazole­ treated and control worms 
(Figure 5B). We also chemically sensitized the 
Pxol-1::gfp strain by incorpora ting the mutant 
allele nx3 of the cuticle collagen gene col-121, 
which was isolated in a screen for hyper­
sensitivity to bisphenol A (Watanabe et al. 
2005). In this background, a 2.7­fold increase 
in GFP+ embryos was observed in DMSO 
treated worms compared with Pxol-1::gfp 
alone, possibly because of increased sensitivity 
to the low aneugenic activity of DMSO 
(Goldstein and Magnano 1988). However, 
the number of GFP+ events captured was also 
dramatically improved: about 220% more 
for the same number of worms sorted. Thus, 
automated detection and sorting of the worms 
is a valuable option for the HTS screening of 
chemical aneuploidy.
Figure 4. Functional validation of selected compounds. (A) Germline apoptosis assay quantification. After exposure to each of the 10 least aneugenic compounds 
in the C. elegans assay or to each of the 10 most aneugenic compounds, we quantified apoptotic levels through the use of the Plim-7ced-1::gfp reporter DMSO 
was the negative control, and the DNA damaging agent camptothecin the positive control. The lower and upper edges of the box plot represent the first and third 
quartiles, respectively, with the median represented as a line within the box; the whiskers extend to ± 1.5 times the interquartile range. (B) DAPI staining of germ-
line nuclei revealed profound germ line defects after exposure to Maneb and TCMTB (bars = 50 µm). Assembled germ lines show areas of reduced nuclear density 
(asterisks), intermixed meiotic stages (red arrowheads), and unequally spaced diakinetic nuclei (white arrows). Insets show high magnification examples of late 
diakinetic nuclei (bars = 4 µm); note that nuclei with chromosomes in a pachytene stage-like organization are present intermixed with diakinetic nuclei in late 
prophase after maneb exposure.
*p < 0.001 compared with DMSO by ANOVA followed by Dunn’s comparison. The numbers of apoptotic nuclei in the 10 least and most aneugenic compounds were highly significantly 
different from each other (p < 0.0001; two-tailed Mann–Whitney U test, 95% CI); 
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Discussion
Our results show the C. elegans assay is an 
efficient and reliable technology for the fast 
screening of chemicals altering germ line func-
tion. We focused on environmental com-
pounds as a mean to address a gap in our 
current ability to assess the potential hazards 
of thousands of untested chemicals. However, 
the assay described here is also applicable to 
other chemical screens, including drug safety 
assessment and small molecule assays for the 
analysis of germ line pathways.
We estimate that the screening time with 
the COPAS BIOSORT (Union Biometrica) 
will consist of 65 hr of exposure followed 
by 45 min of reading for each 96-well plate. 
Because exposures can be performed simul-
taneously and each plate adds only an addi-
tional 45 min of reading time, a library of 
1,000 compounds could be screened in tripli-
cate in as few as 4 days. The running costs of 
the screen are extremely low given that the 
only reagents necessary for the screen are deep 
96-well plates, buffer solution, and bacteria for 
food. By comparison, mammalian reproduc-
tion assays are much costlier and lengthier. 
A typical single-generation rodent reproduc-
tion test involves an 8- to 10-week exposure 
window starting around puberty and com-
prising ≥ 20 pregnancies for each dose group 
(U.S. EPA 1996). Furthermore, mammalian 
cell–based assays do not recapitulate efficiently 
all stages of meiosis and are not suitable for 
large-scale platforms. Thus, we are providing 
a unique whole organism first tier assay that 
examines the outcome of complex cellular and 
developmental processes with short running 
time, modest cost, and high accuracy.
The “Green eggs and Him” output is 
representative of overall levels of aneuploidy 
as evidenced by a) the correlation between 
GFP expression and the presence of germ-
line defects as well as high levels of embry-
onic lethality, a phenotype expected from the 
missegregation of the autosomes and not just 
the X chromosome (Hodgkin 2005; Kelly 
et al. 2000); b) the fact that most genetic 
disruptions of the germ line lead to mis-
segregation of all chromosomes and not just 
the X chromosome (Dernburg et al. 1998; 
Hodgkin et al. 1979; Kelly et al. 2000); and 
c) that exposures to at least two hits from the 
screen, Maneb and TCMTB, show a high 
level of germ line disruption, indicating that 
the GFP readout can indicate the disruption 
of germ line processes. Nonetheless, although 
not performed in this study, a follow-up 
analysis of selected hits should include the 
measurement of embryonic lethality. This 
measurement requires significant time and 
cannot be embedded within an HTS assay. 
However, it will permit further validation 
of the hits as affecting other chromo somes 
besides the X chromosome.
An interesting feature of the screening 
results is that some of the strong aneuploidy- 
inducing hits [see Supplemental Material, 
Tables S2 and S3 (http://dx.doi.org/10.1289/
ehp.1206301)] lack any described mammalian 
reproductive toxicity. Although we cannot 
explain the presence of all of the compounds 
near the top of the list, some of them have 
well-described mammalian germ cell aneu-
genicity [e.g., thiabendazole (ranked seventh at 
65 hr; see Supplemental Material, Table S3)] 
(Mailhes et al. 1997; Schmid et al. 1999). 
The outcome of our screen, together with past 
aneugenic evidence, predicts a potential repro-
ductive hazard of thiabendazole. Finally, some 
compounds are negative hits in the screen, 
implying that they produce less aneuploidy 
than DMSO alone. A possible explanation 
for this would be the undesirable direct inhi-
bition of reporter expression. However, the 
number of chemicals exerting such an effect 
is low (2 of 47 chemicals at 24 hr and 65 hr) 
and is manageable in the context of a first pass 
screening strategy.
A difference in ADME (absorption, dis-
tribution, metabolism, and excretion) param-
eters, such as for thioguanine, will be a likely 
source of false-negatives in C. elegans com-
pared with mammalian systems. Furthermore, 
a potential avenue for improving the screen 
could be the inclusion of dose– response curves 
for each compound. However, a distinct 
advantage to the present approach is the abil-
ity to screen with varying sensitivity or speci-
ficity depending on the application, be it risk 
assessment or the identification of mechanism 
of action. The cutoff criteria for a positive 
hit in the C. elegans assay may be optimized 
accordingly, where a value of 1.2 at the 24-hr 
exposure provides a sensitivity of 80%, and a 
value of 2.3 in the 65-hr exposure provides a 
specificity of 89%. Using this method removes 
many of the aforementioned false-negatives 
or false-positives, respectively. As shown in 
Table 1, higher relative risks for reproductive 
end points such as offspring viability and litter 
size corresponded to lower cutoff values at the 
24-hr time point, and higher relative risk for 
end points such as fertility and ovarian pathol-
ogy corresponded to higher cutoff values or 
the later 65-hr time point. The differing time 
points and cutoff values may provide infor-
mation on varying events in the meiotic pro-
cess, embryonic stages, or specific reproductive 
organs that may be targeted or impaired by 
different chemicals.
Conclusion
With a low cost, high speed, and strong 
predictive value, this technology fulfills the 
requirement for first pass assessment of chemi-
cal hazard, and furthermore, it offers insight 
into germ line disruption as a mechanism of 
reproductive toxicity.
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